Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891092-00-000851
Filing Date
2000-09-22
Accepted
2000-09-22 00:00:00
Documents
1
Group Members
CADUCEUS CAPITAL TRUSTCADUCEUS CAPTITAL II, L.P.ORBIMED ADVISERS INC /CTORBIMED ADVISORS LLCPAINEWEBBER EUCALYPTUS FUND, LLCPAINEWEBBER EUCALYPTUS FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 12158
  Complete submission text file 0000891092-00-000851.txt   14549
Mailing Address 200 BOSTON AVE MEDFORD MA 02155
Business Address 200 BOSTON AVE MEDFORD MA 02155 6173954100
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

EIN.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48819 | Film No.: 727159
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)